OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC327188 Human cDNA pCMV6-XL5 MARK2 (untagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2) transcript variant 5 (10ug) NM_001163296.1 $1300 4-5 weeks
RC228553 Human ORF PS100001 MARK2 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 5 $1040 4-5 weeks
RC228553L1 Human ORF PS100064 Lenti-ORF clone of MARK2 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 5, (10ug) $1410 6-7 weeks
RC228553L2 Human ORF PS100071 Lenti-ORF clone of MARK2 (mGFP-tagged)-Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 5, (10ug) $1550 6-7 weeks
RG228553 Human ORF PS100010 MARK2 (GFP-tagged) - Human MAP/microtubule affinity-regulating kinase 2 (MARK2), transcript variant 5 $1140 4-5 weeks
TF320329 Human shRNA pRFP-C-RS MARK2 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG320329 Human shRNA pGFP-V-RS MARK2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR320329 Human shRNA pRS MARK2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
/ UTR pMirTarget 3`UTR clone of MAP/microtubule affinity-regulating kinase 2 (MARK2) transcript variant 5 for miRNA target validation NM_001163296.1 $595 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title